Angaza (James H. Jackson, Jr., Ph.D.) is a neuroscientist with a background in biomedical research, particularly in psychiatric neuroscience, neurotransmission, neuropharmacology and protein chemistry. Although he has worked with some of the most prominent neuroscientists in the world, he has not been directly involved in research since 1990 when he was involved in TMJ research. Dr. Jackson also has a strong background in the financial markets and traded securities, futures and options on securities and futures for 12 years.